Antifungal agents for preventing fungal infections in solid organ transplant recipients (Q24246678)

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants. Use in prophylaxis of oropharyngeal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Reliability of clinical research on invasive fungal infections: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Clinical spectrum of fungal infections after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Going Beyond the Grand Mean: Subgroup Analysis in Meta-Analysis of Randomised Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Fungal infection in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Emerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Nystatin prophylaxis and treatment in severely immunodepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Revisiting the Source of Candidemia: Skin or Gut?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Invasive aspergillosis in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Prevention of fungal infection in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Antifungal agents for preventing fungal infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

Prophylaxis of Oral Candidiasis With Clotrimazole Troches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Ketoconazole to reduce the need for cyclosporine after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Invasive candidiasis: turning risk into a practical prevention policy?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021

Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004291.PUB2

7 January 2021